Thomas Doyle - Feb 7, 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
SVP, Finance & Accounting
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Stock symbol
KURA
Transactions as of
Feb 7, 2022
Transactions value $
$0
Form type
4
Date filed
2/9/2022, 04:50 PM
Next filing
Jan 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Award $0 +8.39K +126.93% $0.00 15K Feb 7, 2022 Direct F1
holding KURA Common Stock 500 Feb 7, 2022 spouse's 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +39.3K $0.00 39.3K Feb 7, 2022 Common Stock 39.3K $13.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26.
F2 This option vests in 48 equal monthly installments commencing on the grant date.